Published online Dec 24, 2014. doi: 10.5500/wjt.v4.i4.276
Revised: August 12, 2014
Accepted: September 16, 2014
Published online: December 24, 2014
Processing time: 203 Days and 1.9 Hours
Coronary allograft vasculopathy remains one of the leading causes of death beyond the first year post transplant. As a result of denervation following transplantation, patients lack ischaemic symptoms and presentation is often late when the graft is already compromised. Current diagnostic tools are rather invasive, or in case of angiography, significantly lack sensitivity. Therefore a non-invasive tool that could allow early diagnosis would be invaluable.This paper review the disease form its different diagnosis techniques,including new and less invasive diagnostic tools to its pharmacological management and possible treatments.
Core tip: Coronary allograft vasculopathy remains the leading cause of great loss in children after the first year post transplant. This paper offers a state of the art review of the disease from diagnosis including most recent and less invasive tools to management.